Evaluation of the Efficacy of Treatment with Resistol in Patients with Acute Respiratory Virus Infection

Authors

  • Dilorom Kamarovna Ishankulova Samarkand State Medical University, Samarkand, Republic of Uzbekistan
  • Baxtiyor Urakovich Nizomov Samarkand State Medical University, Samarkand, Republic of Uzbekistan

Keywords:

ARVI, PVAS, quality of life, Rezistol

Abstract

The effectiveness of Resistol (Pelargonii radix Extractum Liquidum) was evaluated in 116 patients with acute respiratory viral infections in the conditions of the Jambay CRH polyclinic. According to the results of studies, the appointment of Resistol (Pelargonium sidoides) in combination with symptomatic treatment according to the instructions for patients admitted during the onset or exacerbation of acute respiratory viral infections accelerated the recovery of patients and improved the quality of life, improved the condition of post-viral asthenic syndrome (PVAS).

Downloads

Published

2022-12-01

How to Cite

Ishankulova, D. K. ., & Nizomov, B. U. . (2022). Evaluation of the Efficacy of Treatment with Resistol in Patients with Acute Respiratory Virus Infection. Vital Annex: International Journal of Novel Research in Advanced Sciences, 1(5), 331–333. Retrieved from https://innosci.org/IJNRAS/article/view/534

Issue

Vol. 1 No. 5 (2022): November 2022

Section

Articles